Orchestra BioMed Holdings, Inc.OBIONASDAQ
Loading
Year-over-year operating cash flow growth rate
Latest
3.15%
↑ 121% vs avg
Percentile
P80
Within normal range
Streak
2 yr
Consecutive growthAccelerating
Average
-14.82%
Historical baseline
| Period | Value |
|---|---|
| 2025 | 3.15% |
| 2024 | -9.61% |
| 2023 | -57.49% |
| 2022 | -50.75% |
| 2021 | 25.80% |
| 2020 | 0.00% |